NO20073582L - Sammensetninger og fremgangsmåter for behandling av schizofreni og beslektede tilstander - Google Patents

Sammensetninger og fremgangsmåter for behandling av schizofreni og beslektede tilstander

Info

Publication number
NO20073582L
NO20073582L NO20073582A NO20073582A NO20073582L NO 20073582 L NO20073582 L NO 20073582L NO 20073582 A NO20073582 A NO 20073582A NO 20073582 A NO20073582 A NO 20073582A NO 20073582 L NO20073582 L NO 20073582L
Authority
NO
Norway
Prior art keywords
compositions
methods
related conditions
treating schizophrenia
schizophrenia
Prior art date
Application number
NO20073582A
Other languages
English (en)
Inventor
Ilya Chumakov
Daniel Cohen
Fabio Macciardi
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of NO20073582L publication Critical patent/NO20073582L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO20073582A 2004-12-28 2007-07-11 Sammensetninger og fremgangsmåter for behandling av schizofreni og beslektede tilstander NO20073582L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04293143 2004-12-28
PCT/EP2005/056677 WO2006069907A1 (en) 2004-12-28 2005-12-12 Compositions and methods for treating schizophrenia and related disorders

Publications (1)

Publication Number Publication Date
NO20073582L true NO20073582L (no) 2007-09-28

Family

ID=34931668

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073582A NO20073582L (no) 2004-12-28 2007-07-11 Sammensetninger og fremgangsmåter for behandling av schizofreni og beslektede tilstander

Country Status (8)

Country Link
US (1) US20080254451A1 (no)
EP (1) EP1831395A1 (no)
JP (1) JP2008525000A (no)
AU (1) AU2005321315A1 (no)
CA (1) CA2578072A1 (no)
IL (1) IL184267A0 (no)
NO (1) NO20073582L (no)
WO (1) WO2006069907A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2677339A1 (en) * 2007-02-08 2008-08-14 Powmri Limited Method of diagnosing a neurodegenerative disease
US8680019B2 (en) 2007-08-10 2014-03-25 Protelica, Inc. Universal fibronectin Type III binding-domain libraries
US8470966B2 (en) 2007-08-10 2013-06-25 Protelica, Inc. Universal fibronectin type III binding-domain libraries
US20090176654A1 (en) 2007-08-10 2009-07-09 Protelix, Inc. Universal fibronectin type III binding-domain libraries
CA3045925A1 (en) 2016-12-06 2018-06-14 The Board Of Trustees Of The Leland Stanford Junior University Ciliary neurotrophic factor receptor ligand-binding agents and methods of using the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861719A (en) * 1986-04-25 1989-08-29 Fred Hutchinson Cancer Research Center DNA constructs for retrovirus packaging cell lines
US5278056A (en) * 1988-02-05 1994-01-11 The Trustees Of Columbia University In The City Of New York Retroviral packaging cell lines and process of using same
CS156891A3 (en) * 1990-06-01 1992-04-15 Regeneron Pharma Receptor of a cilary neurotropic factor
MX9701720A (es) * 1994-09-12 1997-06-28 Schering Ag Proceso para la fabricacion de una palidipina modificada, inhibidora de la agregacion plaquetaria inducida por colageno.
US6013516A (en) * 1995-10-06 2000-01-11 The Salk Institute For Biological Studies Vector and method of use for nucleic acid delivery to non-dividing cells
IT1291114B1 (it) * 1997-03-20 1998-12-29 Angeletti P Ist Richerche Bio Varianti del fattore neurotrofico ciliare (cntf) con migliorata selettivita' al recettore, e metodo per la loro selezione
US6818418B1 (en) * 1998-12-10 2004-11-16 Compound Therapeutics, Inc. Protein scaffolds for antibody mimics and other binding proteins
WO2001094605A2 (en) * 2000-06-09 2001-12-13 University Of Florida Research Foundation, Inc. Recombinant aav vectors for gene therapy of obesity
EP1578354A4 (en) * 2002-03-26 2008-04-09 Massachusetts Inst Technology TARGETS, METHODS AND REAGENTS FOR THE DIAGNOSIS AND TREATMENT OF SCHIZOPHRENIA
WO2004022705A2 (en) * 2002-09-04 2004-03-18 Incyte Corporation Neurotransmission-associated proteins

Also Published As

Publication number Publication date
JP2008525000A (ja) 2008-07-17
AU2005321315A1 (en) 2006-07-06
US20080254451A1 (en) 2008-10-16
IL184267A0 (en) 2007-10-31
CA2578072A1 (en) 2006-07-06
WO2006069907A1 (en) 2006-07-06
EP1831395A1 (en) 2007-09-12

Similar Documents

Publication Publication Date Title
NO20200775A1 (no) Fremgangsmåter og sammensetninger for behandling av kreft
DK1888033T3 (da) Fremgangsmåde og sammensætning til behandling af inflammatoriske sygdomme
EP1940423A4 (en) METHODS AND COMPOSITIONS OF TISSUE GENIUS
DK1830838T3 (da) Sammensætninger og fremgangsmåder til behandling af neoplastiske sygdomme
EP1899480A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY CONDITIONS
PT3006040T (pt) Métodos e composições para o tratamento de neuropatias
DK1791791T3 (da) Fremgangsmåder og sammensætninger til behandling af vand
IL193014A0 (en) Methods and compositions for treating schizophrenia
DK1765327T3 (da) Forbindelser, sammensætninger og fremgangsmåder
BRPI0716354A2 (pt) "composiÇço e mÉtodo"
ATE435271T1 (de) Zusammensetzungen zur wäschebehandlung
ATE430187T1 (de) Zusammensetzungen zur wäschebehandlung
PL2529626T3 (pl) Kompozycje i sposoby leczenia lub zapobiegania nowotworowi okrężnicy
IL185056A0 (en) Compositions and methods for treating or preventing flaviviridae infections
DE602005009537D1 (de) Änger mit niedriger zf und assoziiertes verfahren
EP1737482A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES
CR10667A (es) Compositions and methods for diagnosing and treating cancer
EP1961065A4 (en) COMPOSITIONS AND METHOD FOR DIAGNOSIS AND TREATMENT OF CANCER
DE602006002766D1 (de) Gestängeelevator und Verfahren
PT1771201E (pt) Composições e métodos para o tratamento ou prevenção de doenças relacionadas com oxalato
DK1667730T3 (da) Sammensætninger og fremgangsmåder til behandling af inflammatorisk lungesygdom
IL191237A0 (en) Compositions and methods for treating thrombocytopenia
EP2049140A4 (en) BOX AND METHODS FOR TREATING AN INTERVERTEBRAL DISC
EP1885393A4 (en) METHODS AND COMPOSITIONS FOR IMMUNIZATION AGAINST CHLAMYDIA INFECTIONS
FI20040011L (fi) Menetelmä pintojen käsittelemiseksi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application